文献速递甲状腺疾病

妊娠期甲状腺功能不全的目标高危病例筛查:能否改进?

Screening for Thyroid Dysfunction in Pregnancy With Targeted High-Risk Case Finding: Can It Be Improved?
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该横断面研究纳入1832名孕妇,评估基于ATA指南的风险因素进行目标筛查对亚临床甲状腺功能减退症(SCH)和临床甲状腺功能减退症(OH)的检出率。结果显示目标筛查对SCH检出率低于普遍筛查(54% vs 100%,P<0.001),但将BMI 30-39.9 kg/m2和白人背景纳入风险因素后,SCH检出率与普遍筛查相当(81%和88% vs 100%,P=0.220和0.439)。

要点

  • 目标高危筛查对SCH检出率低于普遍筛查,对OH检出率相当。
  • 将BMI 30-39.9 kg/m2和白人背景纳入风险因素可提高SCH检出率至与普遍筛查相当。
  • 高危组占64%,低危组占36%(P<0.001)。

核心结论

  • 目标高危病例筛查对SCH检出效果不佳,但对OH效果较好。
  • 将肥胖(BMI 30-39.9 kg/m2)和白人背景作为风险因素后,SCH检出率与普遍筛查相当。

研究设计与样本

  • 单中心横断面研究,纳入1832名孕妇。
  • 检测甲状腺功能(TSH和游离T4)和铁状态。
  • 高危组(HRG)包括有一个或多个ATA-GL风险因素的孕妇,低危组(LRG)无风险因素。
  • 将BMI 30-39.9 kg/m2或白人背景者归为HRG+,铁缺乏者归为HRG++。

主要发现

  • HRG占64%,LRG占36%(P<0.001)。
  • 所有参与者中SCH占4.5%,OH占0.5%。
  • SCH和OH检出率在LRG与HRG间无显著差异(SCH:46% vs 54%,P=0.560;OH:25% vs 75%,P=0.157)。
  • HRG中SCH检出率低于普遍筛查(54% vs 100%,P<0.001),OH检出率与普遍筛查相当(75%,P=0.596)。
  • HRG+和HRG++中SCH检出率与普遍筛查相当(81%和88% vs 100%,P=0.220和0.439)。

关键数值与推荐

  • SCH和OH的诊断基于美国甲状腺协会(ATA)指南。
  • 高危组定义基于ATA-GL风险因素。

临床怎么用

  • 目标高危筛查可能不足以检出所有SCH病例,考虑将BMI 30-39.9 kg/m2和白人背景纳入风险因素以提高检出率。

局限性

  • 单中心横断面研究,结果外推需谨慎。
  • 未报告普遍筛查组的实际检出率,仅以100%作为参照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT AND OBJECTIVE: Targeted screening is proposed for the detection of thyroid dysfunction in pregnant women rather than universal screening (US). We aimed to determine the detection rate of subclinical hypothyroidism (SCH) and overt hypothyroidism (OH) based on American Thyroid Association guidelines (ATA-GL) and whether it could be improved. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study of 1832 pregnant women in a single center. Thyroid function (TSH and free T4) and iron status were determined. The high-risk group (HRG) included women with one or more ATA-GL risk factors and the low-risk group (LRG) included women without. Participants with other risk factors [body mass index (BMI) 30 to 39.9 kg/m2, Caucasian background] were classified as HRG+ and those with iron deficiency as HRG++. RESULTS: The HRG included 64% of women and the LRG included 36% (P < 0.001). Of all participants, 4.5% had SCH and 0.5% OH. The detection rate of SCH and OH was comparable between the LRG and HRG (46% vs 54% and 25% vs 75%; P = 0.560 and 0.157, respectively). In the HRG, the detection rate of SCH was lower than that of US (54% vs 100%; P < 0.001), but that of OH was comparable (75%; P = 0.596). The detection rate of SCH in the HRG+ and HRG++ was comparable to that in the US group (81% and 88% vs 100%; P = 0.220 and 0.439, respectively). CONCLUSIONS: Targeted high-risk case finding screening was not effective for the detection of SCH but performed better for OH. When obesity in the range BMI 30 to 39.9 kg/m2 and a Caucasian background were included as risk factors, the detection rate of SCH became comparable with that of US.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Sitoris G, Veltri F, Kleynen P, et al. Screening for Thyroid Dysfunction in Pregnancy With Targeted High-Risk Case Finding: Can It Be Improved? J Clin Endocrinol Metab. 2019. PMID: 30608533. doi:10.1210/jc.2018-02303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。